Telos Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,816
| Closed | -$2.51M | – | 204 |
|
|
2024
Q4 | $2.51M | Buy |
27,816
+1,710
| +7% | +$154K | 0.27% | 91 |
|
|
2024
Q3 | $2.58M | Sell |
26,106
-270
| -1% | -$26.7K | 0.27% | 91 |
|
|
2024
Q2 | $2.45M | Buy |
26,376
+91
| +0.3% | +$8.44K | 0.27% | 87 |
|
|
2024
Q1 | $2.49M | Buy |
26,285
+420
| +2% | +$39.9K | 0.28% | 89 |
|
|
2023
Q4 | $2.31M | Sell |
25,865
-535
| -2% | -$47.8K | 0.28% | 86 |
|
|
2023
Q3 | $1.93M | Sell |
26,400
-305
| -1% | -$22.3K | 0.27% | 86 |
|
|
2023
Q2 | $2.22M | Sell |
26,705
-170
| -0.6% | -$14.1K | 0.3% | 85 |
|
|
2023
Q1 | $2.05M | Sell |
26,875
-5
| -0% | -$381 | 0.29% | 86 |
|
|
2022
Q4 | $2.23M | Buy |
26,880
+325
| +1% | +$27K | 0.32% | 85 |
|
|
2022
Q3 | $2.11M | Buy |
26,555
+175
| +0.7% | +$13.9K | 0.35% | 83 |
|
|
2022
Q2 | $1.96M | Buy |
+26,380
| New | +$1.96M | 0.3% | 92 |
|